Study Overview: This research is for adults with a type of blood cancer called Multiple Myeloma (MM) that has returned or is not responding to treatment. The study is testing an investigational medication given under the skin with other medicines, carfilzomib and dexamethasone, to see how well they work together.

• The study lasts about 13 months, including a 1-month screening and 12 months of treatment.
• Participants will visit the study site regularly for treatment and check-ups.
• Eligibility includes having MM with 1-3 past treatments and measurable disease.

Eligibility Requirements: You must have a confirmed diagnosis of MM, have had at least one but no more than three previous treatments, and not be on certain other treatments close to the study start. You cannot join if you have certain allergies or conditions, or if you’ve had specific treatments recently. Both men and women must agree to use contraception during the study.

If interested, check with your doctor to see if this study might be a fit for you. 🤔